Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Arvind Jain

B.Pharm, M.Pharm, PhD

Postdoctoral Research Scientist

My current research work at Prof TH Rabbitts Lab is focused on formulation and development of various targeted nanoparticulate systems for the intracellular delivery of drugs and drug surrogates (antibody fragments/ nucleic acids) leading to intervention of protein-protein interactions at subcellular level especially cancer associated oncogenic protein interactions.

Previously, I studied BPharm from Devi Ahliya University and MPharm in Pharmaeutical Biotechnology from Dr HS Gour University, India. During my Master’s resarch project I synthesized various diblock and triblock (BAB and ABA) coploymers of PLA and PEG for their potential application as a mucosal vaccine delivery system. In 2008, I joined ISF college of Pharmacy, Moga where I taught undergraduate and post graduate modules, and co-supervised a Master’s research project. Right before leaving India for my doctoral studies I was working as an associate at Indian Institute of Technology Kanpur, where I developed and characterised electrosparyed polysccharide microparticles for colon targeting application.

During my PhD in 2010 at School of Pharmacy, Queen’s University Belfast with Dr VL Kett,  I developed a novel nanoparticle-in-nanoparticle system for the prolonged and 
effective gene delivery to the posterior eye as a prophylactic measure to Retinopathy of Prematurity. A range of  physicochemical and thermodynamic studies were performed to regulate the condensation of pDNA with a cationic cell penetrating
peptide, RALA,  to achieve the nanoparticles 
of defined size distribution. These nanoparticles were then encapsualted within the biodegradable PLA-PEG nanoparticles to guide their path to the posterior eye.

Recent publications

More publications